User login
See Photos from VRIC
This year we have photographic proof – VRIC is a great experience for researchers. Invigorating discussions, great speakers, inspiration, new ideas – it was all part of the Vascular Research Initiatives Conference in Minneapolis. See our photo album on Flickr or watch the slide show version on YouTube.
This year we have photographic proof – VRIC is a great experience for researchers. Invigorating discussions, great speakers, inspiration, new ideas – it was all part of the Vascular Research Initiatives Conference in Minneapolis. See our photo album on Flickr or watch the slide show version on YouTube.
This year we have photographic proof – VRIC is a great experience for researchers. Invigorating discussions, great speakers, inspiration, new ideas – it was all part of the Vascular Research Initiatives Conference in Minneapolis. See our photo album on Flickr or watch the slide show version on YouTube.
Going to VAM? Don’t Forget the Mobile App
Have VAM at your fingertips with the Mobile App. You can:
- Take your MOC assessment tests via a link within the app
- Access all abstracts, schedules and speaker bios
- Create your own agenda of sessions and events
- Bookmark abstracts of interest
- View maps
- View attendees and private message them
- Share photos and status updates …
- ... and much more
There’s a version for iPhones and one for Android phones.
Have VAM at your fingertips with the Mobile App. You can:
- Take your MOC assessment tests via a link within the app
- Access all abstracts, schedules and speaker bios
- Create your own agenda of sessions and events
- Bookmark abstracts of interest
- View maps
- View attendees and private message them
- Share photos and status updates …
- ... and much more
There’s a version for iPhones and one for Android phones.
Have VAM at your fingertips with the Mobile App. You can:
- Take your MOC assessment tests via a link within the app
- Access all abstracts, schedules and speaker bios
- Create your own agenda of sessions and events
- Bookmark abstracts of interest
- View maps
- View attendees and private message them
- Share photos and status updates …
- ... and much more
There’s a version for iPhones and one for Android phones.
Are you prepared for MACRA?
MACRA (Medicare Access and CHIP Reauthorization Act of 2015) replaces the flawed sustainable growth rate (SGR) formula and significantly changes the way Medicare pays physicians.
Many things about the Affordable Care Act (ACA; Obamacare) are likely to change under the new administration, but MACRA and the commitment to cost-effective, value-based care is here to stay. MACRA is separate from the ACA. Congress overwhelmingly passed MACRA legislation with bipartisan support. MACRA will eventually transition physicians toward more value-based payments.
It is important to understand MACRA to ensure you are doing everything required under the current rules in 2017. Ignore MACRA in 2017 and you will face an automatic reduction of 4% to your payments under Medicare in 2019.
AGA offers educational webinars and videos to help you prepare. Visit gastro.org/MACRA to learn more.
MACRA (Medicare Access and CHIP Reauthorization Act of 2015) replaces the flawed sustainable growth rate (SGR) formula and significantly changes the way Medicare pays physicians.
Many things about the Affordable Care Act (ACA; Obamacare) are likely to change under the new administration, but MACRA and the commitment to cost-effective, value-based care is here to stay. MACRA is separate from the ACA. Congress overwhelmingly passed MACRA legislation with bipartisan support. MACRA will eventually transition physicians toward more value-based payments.
It is important to understand MACRA to ensure you are doing everything required under the current rules in 2017. Ignore MACRA in 2017 and you will face an automatic reduction of 4% to your payments under Medicare in 2019.
AGA offers educational webinars and videos to help you prepare. Visit gastro.org/MACRA to learn more.
MACRA (Medicare Access and CHIP Reauthorization Act of 2015) replaces the flawed sustainable growth rate (SGR) formula and significantly changes the way Medicare pays physicians.
Many things about the Affordable Care Act (ACA; Obamacare) are likely to change under the new administration, but MACRA and the commitment to cost-effective, value-based care is here to stay. MACRA is separate from the ACA. Congress overwhelmingly passed MACRA legislation with bipartisan support. MACRA will eventually transition physicians toward more value-based payments.
It is important to understand MACRA to ensure you are doing everything required under the current rules in 2017. Ignore MACRA in 2017 and you will face an automatic reduction of 4% to your payments under Medicare in 2019.
AGA offers educational webinars and videos to help you prepare. Visit gastro.org/MACRA to learn more.
2018 AGA Fellows Program now accepting applications
The application period for the 2018 AGA Fellows Program is now open. The program recognizes members whose accomplishments demonstrate personal commitment to the field of gastroenterology with the distinction of fellowship.
AGA Fellows receive this honor from AGA for their superior professional achievement in clinical private or academic practice and in basic or clinical research.
AGA Fellows receive:
- The privilege of using the designation “AGAF” in professional activities.
- An official certificate and pin denoting your status.
- A listing on the AGA website.
And more.
Apply today to join this international community of excellence.
Find more information, including the list of benefits and criteria for fellowship, at www.gastro.org/fellowship. The deadline for application submissions is Monday, July 31, 2017.
The application period for the 2018 AGA Fellows Program is now open. The program recognizes members whose accomplishments demonstrate personal commitment to the field of gastroenterology with the distinction of fellowship.
AGA Fellows receive this honor from AGA for their superior professional achievement in clinical private or academic practice and in basic or clinical research.
AGA Fellows receive:
- The privilege of using the designation “AGAF” in professional activities.
- An official certificate and pin denoting your status.
- A listing on the AGA website.
And more.
Apply today to join this international community of excellence.
Find more information, including the list of benefits and criteria for fellowship, at www.gastro.org/fellowship. The deadline for application submissions is Monday, July 31, 2017.
The application period for the 2018 AGA Fellows Program is now open. The program recognizes members whose accomplishments demonstrate personal commitment to the field of gastroenterology with the distinction of fellowship.
AGA Fellows receive this honor from AGA for their superior professional achievement in clinical private or academic practice and in basic or clinical research.
AGA Fellows receive:
- The privilege of using the designation “AGAF” in professional activities.
- An official certificate and pin denoting your status.
- A listing on the AGA website.
And more.
Apply today to join this international community of excellence.
Find more information, including the list of benefits and criteria for fellowship, at www.gastro.org/fellowship. The deadline for application submissions is Monday, July 31, 2017.
AGA recognizes 52 investigators with research funding
The AGA Research Foundation is thrilled to award 52 researchers with research funding in the 2017 award year.
“The AGA Research Foundation has a proven track record of funding young investigators who subsequently achieve great success in research. We are confident that the 2017 class will be no exception,” said Robert S. Sandler, MD, MPH, AGAF, chair, AGA Research Foundation. “AGA is honored to invest in this year’s award recipients and looks forward to seeing how each research project contributes to advancing the field of gastroenterology.”
The AGA Research Award Program serves to support talented investigators who are pursuing careers in digestive disease research. A grant from the AGA Research Foundation ensures that a major proportion of the recipient’s time is protected for research.
The awards program is made possible thanks to generous donors and funders contributing to the AGA Research Foundation. Show your support for GI research.
To learn about upcoming research funding opportunities, and to view the list of this years’ winners, visit www.gastro.org/awards.
This year’s honorees were recognized during several AGA Research Foundation events at Digestive Disease Week® 2017, which took place May 6-9 in Chicago, IL.
The AGA Research Foundation is thrilled to award 52 researchers with research funding in the 2017 award year.
“The AGA Research Foundation has a proven track record of funding young investigators who subsequently achieve great success in research. We are confident that the 2017 class will be no exception,” said Robert S. Sandler, MD, MPH, AGAF, chair, AGA Research Foundation. “AGA is honored to invest in this year’s award recipients and looks forward to seeing how each research project contributes to advancing the field of gastroenterology.”
The AGA Research Award Program serves to support talented investigators who are pursuing careers in digestive disease research. A grant from the AGA Research Foundation ensures that a major proportion of the recipient’s time is protected for research.
The awards program is made possible thanks to generous donors and funders contributing to the AGA Research Foundation. Show your support for GI research.
To learn about upcoming research funding opportunities, and to view the list of this years’ winners, visit www.gastro.org/awards.
This year’s honorees were recognized during several AGA Research Foundation events at Digestive Disease Week® 2017, which took place May 6-9 in Chicago, IL.
The AGA Research Foundation is thrilled to award 52 researchers with research funding in the 2017 award year.
“The AGA Research Foundation has a proven track record of funding young investigators who subsequently achieve great success in research. We are confident that the 2017 class will be no exception,” said Robert S. Sandler, MD, MPH, AGAF, chair, AGA Research Foundation. “AGA is honored to invest in this year’s award recipients and looks forward to seeing how each research project contributes to advancing the field of gastroenterology.”
The AGA Research Award Program serves to support talented investigators who are pursuing careers in digestive disease research. A grant from the AGA Research Foundation ensures that a major proportion of the recipient’s time is protected for research.
The awards program is made possible thanks to generous donors and funders contributing to the AGA Research Foundation. Show your support for GI research.
To learn about upcoming research funding opportunities, and to view the list of this years’ winners, visit www.gastro.org/awards.
This year’s honorees were recognized during several AGA Research Foundation events at Digestive Disease Week® 2017, which took place May 6-9 in Chicago, IL.
Contribute to Clowes Lecture Fund
The recent annual Vascular Research Initiatives Conference featured the inaugural Alexander W. Clowes Distinguished Lecture. The invited presentation – planned to be a yearly event – honors the late Alexander Clowes, a vascular surgeon, scientist and SVS Lifetime Achievement Award-winner, and seeks to continue his considerable legacy.
The SVS Foundation has established a fund for donations to support the Clowes Distinguished Lecture in perpetuity. Learn more about the lecture, Dr. Clowes and how to contribute here.
The recent annual Vascular Research Initiatives Conference featured the inaugural Alexander W. Clowes Distinguished Lecture. The invited presentation – planned to be a yearly event – honors the late Alexander Clowes, a vascular surgeon, scientist and SVS Lifetime Achievement Award-winner, and seeks to continue his considerable legacy.
The SVS Foundation has established a fund for donations to support the Clowes Distinguished Lecture in perpetuity. Learn more about the lecture, Dr. Clowes and how to contribute here.
The recent annual Vascular Research Initiatives Conference featured the inaugural Alexander W. Clowes Distinguished Lecture. The invited presentation – planned to be a yearly event – honors the late Alexander Clowes, a vascular surgeon, scientist and SVS Lifetime Achievement Award-winner, and seeks to continue his considerable legacy.
The SVS Foundation has established a fund for donations to support the Clowes Distinguished Lecture in perpetuity. Learn more about the lecture, Dr. Clowes and how to contribute here.
VAM 2017 Features Alliances and Teamwork
This year’s Vascular Annual Meeting could be subtitled: “The Year of Inter-Society Collaboration.”
Last year, joint sessions with specialty societies that have overlapping interests proved so popular that the number of such sessions was expanded for 2017.
“These sessions provide a multidisciplinary perspective on our common problems, and showcase the SVS’ leadership role in vascular disease diagnosis and management,” said Dr. Ron Dalman, chair of the SVS VAM Program Committee.
“While our specialty encompasses broad expertise across the spectrum of vascular disease, as SVS members we also are interested in what we can learn from others. We want to advance the field, share information and hear how other perspectives may contribute to improved patient care.”
Dr. Kellie Brown, chair of the SVS Postgraduate Education Committee, agreed. “Collaboration helps us have a broader impact on disease management,” she said.
Seven societies are working with SVS members on eight joint programs, nearly double the number in 2016. They are: American Podiatric Medical Association, American Venous Forum, European Society for Vascular Surgery, Society of Thoracic Surgeons, Society for Vascular Medicine, Society for Vascular Nursing and the Society for Vascular Ultrasound.
Here are the 2017 joint sessions:
Wednesday, May 31Postgraduate course2 – 5 p.m.The APMA returns with another joint postgraduate course, “Advances in Wound Care and Limb Management.”
Friday, June 2Concurrent Sessions3:30 – 5 p.m.C5: SVS/ESVS: “Joint Debate Session”C6: SVS/STS: “Sharing Common Ground for Cardiovascular Problems”C7: SVS/AVF: “How and When to Treat Deep Venous Obstructions”
Saturday, June 3Concurrent Sessions10:30 a.m. – 12 p.m.C12: SVS/SVM: “Medical Management of Vascular Disease”C13: SVS/SVN: “Building the Vascular Team – Evolving Collaboration of Surgeons and Nurses”C14: SVS/SVU: “Organization, Operation and Management of a Vascular Laboratory”1:30 – 5:15 p.m. SVS/STS Summit: “Advances and Controversies in the Management of Complex Thoracoabdominal Aneurysmal Disease and Type B Aortic Dissection.” STS is co-sponsoring the session. Moderators for the thoracoabdominal portion are Dr. Jason T. Lee (SVS) and Dr. Wilson Szeto (STS); moderators for the portion on Type B aortic dissection are Dr. Matthew Eagleton (SVS) and Dr. Michael Fischbein (STS).
This year’s Vascular Annual Meeting could be subtitled: “The Year of Inter-Society Collaboration.”
Last year, joint sessions with specialty societies that have overlapping interests proved so popular that the number of such sessions was expanded for 2017.
“These sessions provide a multidisciplinary perspective on our common problems, and showcase the SVS’ leadership role in vascular disease diagnosis and management,” said Dr. Ron Dalman, chair of the SVS VAM Program Committee.
“While our specialty encompasses broad expertise across the spectrum of vascular disease, as SVS members we also are interested in what we can learn from others. We want to advance the field, share information and hear how other perspectives may contribute to improved patient care.”
Dr. Kellie Brown, chair of the SVS Postgraduate Education Committee, agreed. “Collaboration helps us have a broader impact on disease management,” she said.
Seven societies are working with SVS members on eight joint programs, nearly double the number in 2016. They are: American Podiatric Medical Association, American Venous Forum, European Society for Vascular Surgery, Society of Thoracic Surgeons, Society for Vascular Medicine, Society for Vascular Nursing and the Society for Vascular Ultrasound.
Here are the 2017 joint sessions:
Wednesday, May 31Postgraduate course2 – 5 p.m.The APMA returns with another joint postgraduate course, “Advances in Wound Care and Limb Management.”
Friday, June 2Concurrent Sessions3:30 – 5 p.m.C5: SVS/ESVS: “Joint Debate Session”C6: SVS/STS: “Sharing Common Ground for Cardiovascular Problems”C7: SVS/AVF: “How and When to Treat Deep Venous Obstructions”
Saturday, June 3Concurrent Sessions10:30 a.m. – 12 p.m.C12: SVS/SVM: “Medical Management of Vascular Disease”C13: SVS/SVN: “Building the Vascular Team – Evolving Collaboration of Surgeons and Nurses”C14: SVS/SVU: “Organization, Operation and Management of a Vascular Laboratory”1:30 – 5:15 p.m. SVS/STS Summit: “Advances and Controversies in the Management of Complex Thoracoabdominal Aneurysmal Disease and Type B Aortic Dissection.” STS is co-sponsoring the session. Moderators for the thoracoabdominal portion are Dr. Jason T. Lee (SVS) and Dr. Wilson Szeto (STS); moderators for the portion on Type B aortic dissection are Dr. Matthew Eagleton (SVS) and Dr. Michael Fischbein (STS).
This year’s Vascular Annual Meeting could be subtitled: “The Year of Inter-Society Collaboration.”
Last year, joint sessions with specialty societies that have overlapping interests proved so popular that the number of such sessions was expanded for 2017.
“These sessions provide a multidisciplinary perspective on our common problems, and showcase the SVS’ leadership role in vascular disease diagnosis and management,” said Dr. Ron Dalman, chair of the SVS VAM Program Committee.
“While our specialty encompasses broad expertise across the spectrum of vascular disease, as SVS members we also are interested in what we can learn from others. We want to advance the field, share information and hear how other perspectives may contribute to improved patient care.”
Dr. Kellie Brown, chair of the SVS Postgraduate Education Committee, agreed. “Collaboration helps us have a broader impact on disease management,” she said.
Seven societies are working with SVS members on eight joint programs, nearly double the number in 2016. They are: American Podiatric Medical Association, American Venous Forum, European Society for Vascular Surgery, Society of Thoracic Surgeons, Society for Vascular Medicine, Society for Vascular Nursing and the Society for Vascular Ultrasound.
Here are the 2017 joint sessions:
Wednesday, May 31Postgraduate course2 – 5 p.m.The APMA returns with another joint postgraduate course, “Advances in Wound Care and Limb Management.”
Friday, June 2Concurrent Sessions3:30 – 5 p.m.C5: SVS/ESVS: “Joint Debate Session”C6: SVS/STS: “Sharing Common Ground for Cardiovascular Problems”C7: SVS/AVF: “How and When to Treat Deep Venous Obstructions”
Saturday, June 3Concurrent Sessions10:30 a.m. – 12 p.m.C12: SVS/SVM: “Medical Management of Vascular Disease”C13: SVS/SVN: “Building the Vascular Team – Evolving Collaboration of Surgeons and Nurses”C14: SVS/SVU: “Organization, Operation and Management of a Vascular Laboratory”1:30 – 5:15 p.m. SVS/STS Summit: “Advances and Controversies in the Management of Complex Thoracoabdominal Aneurysmal Disease and Type B Aortic Dissection.” STS is co-sponsoring the session. Moderators for the thoracoabdominal portion are Dr. Jason T. Lee (SVS) and Dr. Wilson Szeto (STS); moderators for the portion on Type B aortic dissection are Dr. Matthew Eagleton (SVS) and Dr. Michael Fischbein (STS).
Learn Ins and Outs of Launching a Multicenter Clinical Trial
To help SVS members learn the necessary steps of setting up a multicenter clinical research study, this year’s Vascular Annual Meeting offers “The Nuts and Bolts of a Multicenter Clinical Trial.” The concurrent session will be held from 5 to 6:30 p.m. Wednesday, VAM’s opening day.
“The most accepted method of definitively answering questions is a clinical trial,” said SVS Clinical Research Committee Chair and co-moderator, Dr. Raul Guzman. Though many SVS members have participated in multicenter trials, “They’re not easy endeavors,” said Dr. Guzman. “It takes time, commitment and money to really push forward an idea for a multicenter trial from the ground up.”
“Nuts and Bolts” will provide an insider’s view of effective approaches and processes for launching a multicenter clinical trial, focusing on the best strategies and the challenges involved. “We hope that at the end of the session, attendees will have sufficient detail about this process so they could begin their own trial. We want to provide an initial education,” Dr. Guzman said.
Speakers include SVS members who are successful clinical investigators:
Dr. Brajesh Lal, will speak on “How to Get Started – Perspectives from CREST and CREST-2”
Dr. Alik Farber, “Trial Execution – Tips from the BEST-CLI Trial Investigators”
Dr. B. Timothy Baxter, “The End Game, Finishing Your Trial – How We Did It in NTA^3CT”
Dr. C. Keith Ozaki, “The Small Multicenter Randomized Trial – Involving Your Friends and Neighbors”
Dr. Philip Goodney, “Patient-Oriented Research – A Multicenter Approach to PCORI Trials”
“A discussion about how to overcome challenges and avoid potential pitfalls that can be encountered during the various stages of trial execution are an important part of the course. “Our speakers will discuss not only what they did well, but what they could do better,” said Dr. Guzman.
Many members have questions that need answers, he said. “I would venture to say that most SVS members have had an idea for a clinical trial. They’ve formed the basis of a trial but there are so many challenges that they’ve been discouraged. One of the questions is, “Where do you even start?’
“We think we’ll be able to answer that for them,” Dr. Guzman said.
Wednesday, May 31
5 – 6:30 p.m.
C2: The Nuts and Bolts of a Multicenter Clinical Trial
To help SVS members learn the necessary steps of setting up a multicenter clinical research study, this year’s Vascular Annual Meeting offers “The Nuts and Bolts of a Multicenter Clinical Trial.” The concurrent session will be held from 5 to 6:30 p.m. Wednesday, VAM’s opening day.
“The most accepted method of definitively answering questions is a clinical trial,” said SVS Clinical Research Committee Chair and co-moderator, Dr. Raul Guzman. Though many SVS members have participated in multicenter trials, “They’re not easy endeavors,” said Dr. Guzman. “It takes time, commitment and money to really push forward an idea for a multicenter trial from the ground up.”
“Nuts and Bolts” will provide an insider’s view of effective approaches and processes for launching a multicenter clinical trial, focusing on the best strategies and the challenges involved. “We hope that at the end of the session, attendees will have sufficient detail about this process so they could begin their own trial. We want to provide an initial education,” Dr. Guzman said.
Speakers include SVS members who are successful clinical investigators:
Dr. Brajesh Lal, will speak on “How to Get Started – Perspectives from CREST and CREST-2”
Dr. Alik Farber, “Trial Execution – Tips from the BEST-CLI Trial Investigators”
Dr. B. Timothy Baxter, “The End Game, Finishing Your Trial – How We Did It in NTA^3CT”
Dr. C. Keith Ozaki, “The Small Multicenter Randomized Trial – Involving Your Friends and Neighbors”
Dr. Philip Goodney, “Patient-Oriented Research – A Multicenter Approach to PCORI Trials”
“A discussion about how to overcome challenges and avoid potential pitfalls that can be encountered during the various stages of trial execution are an important part of the course. “Our speakers will discuss not only what they did well, but what they could do better,” said Dr. Guzman.
Many members have questions that need answers, he said. “I would venture to say that most SVS members have had an idea for a clinical trial. They’ve formed the basis of a trial but there are so many challenges that they’ve been discouraged. One of the questions is, “Where do you even start?’
“We think we’ll be able to answer that for them,” Dr. Guzman said.
Wednesday, May 31
5 – 6:30 p.m.
C2: The Nuts and Bolts of a Multicenter Clinical Trial
To help SVS members learn the necessary steps of setting up a multicenter clinical research study, this year’s Vascular Annual Meeting offers “The Nuts and Bolts of a Multicenter Clinical Trial.” The concurrent session will be held from 5 to 6:30 p.m. Wednesday, VAM’s opening day.
“The most accepted method of definitively answering questions is a clinical trial,” said SVS Clinical Research Committee Chair and co-moderator, Dr. Raul Guzman. Though many SVS members have participated in multicenter trials, “They’re not easy endeavors,” said Dr. Guzman. “It takes time, commitment and money to really push forward an idea for a multicenter trial from the ground up.”
“Nuts and Bolts” will provide an insider’s view of effective approaches and processes for launching a multicenter clinical trial, focusing on the best strategies and the challenges involved. “We hope that at the end of the session, attendees will have sufficient detail about this process so they could begin their own trial. We want to provide an initial education,” Dr. Guzman said.
Speakers include SVS members who are successful clinical investigators:
Dr. Brajesh Lal, will speak on “How to Get Started – Perspectives from CREST and CREST-2”
Dr. Alik Farber, “Trial Execution – Tips from the BEST-CLI Trial Investigators”
Dr. B. Timothy Baxter, “The End Game, Finishing Your Trial – How We Did It in NTA^3CT”
Dr. C. Keith Ozaki, “The Small Multicenter Randomized Trial – Involving Your Friends and Neighbors”
Dr. Philip Goodney, “Patient-Oriented Research – A Multicenter Approach to PCORI Trials”
“A discussion about how to overcome challenges and avoid potential pitfalls that can be encountered during the various stages of trial execution are an important part of the course. “Our speakers will discuss not only what they did well, but what they could do better,” said Dr. Guzman.
Many members have questions that need answers, he said. “I would venture to say that most SVS members have had an idea for a clinical trial. They’ve formed the basis of a trial but there are so many challenges that they’ve been discouraged. One of the questions is, “Where do you even start?’
“We think we’ll be able to answer that for them,” Dr. Guzman said.
Wednesday, May 31
5 – 6:30 p.m.
C2: The Nuts and Bolts of a Multicenter Clinical Trial
Fulfillment in giving through insurance
Robert De Marco, MD, FCCP, was one of the first Champions Circle and Founder’s Society donors to make a major gift through insurance. We thank the De Marco family for their support in championing lung health, and it’s our pleasure to share the highlights of a recent interview with Dr. De Marco.
Why did you choose to give through insurance?
How was the process? Did you know anything about giving through insurance beforehand?
I knew nothing about donating insurance. I heard about it during a board strategy session and realized I had a policy that could be donated. I contacted my insurance company. I was sent forms, which were easy to fill out. The forms were then forwarded to CHEST for some signatures, and it was completed. It could not have been easier.
Would you recommend this method of giving to other donors?
Absolutely. If this policy isn’t vital to your family after you are gone, there could not be a better choice.
Why was this choice right for you and your family?
If you must take a significant amount of money out of your savings to make a sizable donation, you can put a serious dent in your retirement income. To be able to make that gift without any effect on my savings is a win-win for everyone.
Why do you continue to give to the CHEST Foundation?
I have spent my whole career trying to deal with diseases of the chest. What better way to sustain my efforts than to support a foundation dedicated to my life’s dreams? There is nothing more fulfilling than helping fund research or a project that could forever change the future of our patients’ lives. I truly believe we, as a group, are on the right path to succeeding in doing just that.
How is giving to the CHEST Foundation fulfilling to you?
How can any effort that will make the lives of our patients better not be fulfilling? Giving my time and effort without the expectation of something in return is an amazing feeling—one that I hope many donors in the future will realize. Just being a part of this great organization is a phenomenal experience.
GIFTS OF LIFE INSURANCE
Easy Solutions for a Greater Impact
If you own a life insurance policy that is no longer needed for its original purpose, you may consider gifting it to the CHEST Foundation.
You can also create a new policy naming the CHEST Foundation as the owner and beneficiary. An annual gift equal to the insurance premium can be given, which would provide you with a charitable deduction. The foundation would then direct the funds to the insurance provider.
This is an excellent win-win solution for you and the CHEST Foundation. For more information on these and other ways to support the CHEST Foundation, confidentially and with no obligation, contact Rudy Anderson at [email protected] or 224/521-9492.
Robert De Marco, MD, FCCP, was one of the first Champions Circle and Founder’s Society donors to make a major gift through insurance. We thank the De Marco family for their support in championing lung health, and it’s our pleasure to share the highlights of a recent interview with Dr. De Marco.
Why did you choose to give through insurance?
How was the process? Did you know anything about giving through insurance beforehand?
I knew nothing about donating insurance. I heard about it during a board strategy session and realized I had a policy that could be donated. I contacted my insurance company. I was sent forms, which were easy to fill out. The forms were then forwarded to CHEST for some signatures, and it was completed. It could not have been easier.
Would you recommend this method of giving to other donors?
Absolutely. If this policy isn’t vital to your family after you are gone, there could not be a better choice.
Why was this choice right for you and your family?
If you must take a significant amount of money out of your savings to make a sizable donation, you can put a serious dent in your retirement income. To be able to make that gift without any effect on my savings is a win-win for everyone.
Why do you continue to give to the CHEST Foundation?
I have spent my whole career trying to deal with diseases of the chest. What better way to sustain my efforts than to support a foundation dedicated to my life’s dreams? There is nothing more fulfilling than helping fund research or a project that could forever change the future of our patients’ lives. I truly believe we, as a group, are on the right path to succeeding in doing just that.
How is giving to the CHEST Foundation fulfilling to you?
How can any effort that will make the lives of our patients better not be fulfilling? Giving my time and effort without the expectation of something in return is an amazing feeling—one that I hope many donors in the future will realize. Just being a part of this great organization is a phenomenal experience.
GIFTS OF LIFE INSURANCE
Easy Solutions for a Greater Impact
If you own a life insurance policy that is no longer needed for its original purpose, you may consider gifting it to the CHEST Foundation.
You can also create a new policy naming the CHEST Foundation as the owner and beneficiary. An annual gift equal to the insurance premium can be given, which would provide you with a charitable deduction. The foundation would then direct the funds to the insurance provider.
This is an excellent win-win solution for you and the CHEST Foundation. For more information on these and other ways to support the CHEST Foundation, confidentially and with no obligation, contact Rudy Anderson at [email protected] or 224/521-9492.
Robert De Marco, MD, FCCP, was one of the first Champions Circle and Founder’s Society donors to make a major gift through insurance. We thank the De Marco family for their support in championing lung health, and it’s our pleasure to share the highlights of a recent interview with Dr. De Marco.
Why did you choose to give through insurance?
How was the process? Did you know anything about giving through insurance beforehand?
I knew nothing about donating insurance. I heard about it during a board strategy session and realized I had a policy that could be donated. I contacted my insurance company. I was sent forms, which were easy to fill out. The forms were then forwarded to CHEST for some signatures, and it was completed. It could not have been easier.
Would you recommend this method of giving to other donors?
Absolutely. If this policy isn’t vital to your family after you are gone, there could not be a better choice.
Why was this choice right for you and your family?
If you must take a significant amount of money out of your savings to make a sizable donation, you can put a serious dent in your retirement income. To be able to make that gift without any effect on my savings is a win-win for everyone.
Why do you continue to give to the CHEST Foundation?
I have spent my whole career trying to deal with diseases of the chest. What better way to sustain my efforts than to support a foundation dedicated to my life’s dreams? There is nothing more fulfilling than helping fund research or a project that could forever change the future of our patients’ lives. I truly believe we, as a group, are on the right path to succeeding in doing just that.
How is giving to the CHEST Foundation fulfilling to you?
How can any effort that will make the lives of our patients better not be fulfilling? Giving my time and effort without the expectation of something in return is an amazing feeling—one that I hope many donors in the future will realize. Just being a part of this great organization is a phenomenal experience.
GIFTS OF LIFE INSURANCE
Easy Solutions for a Greater Impact
If you own a life insurance policy that is no longer needed for its original purpose, you may consider gifting it to the CHEST Foundation.
You can also create a new policy naming the CHEST Foundation as the owner and beneficiary. An annual gift equal to the insurance premium can be given, which would provide you with a charitable deduction. The foundation would then direct the funds to the insurance provider.
This is an excellent win-win solution for you and the CHEST Foundation. For more information on these and other ways to support the CHEST Foundation, confidentially and with no obligation, contact Rudy Anderson at [email protected] or 224/521-9492.
CHEST gets the word out with Reddit
Drs. Simpson, Hogarth, and Moores told Reddit to ask them anything—here’s what happened next.
“Is there an organ or system that sepsis generally targets?”
“If I’m going to be in the back of a cramped car cross country for 16 hours straight, should I take an aspirin beforehand to cut down risk of DVT?”
“Hello Doctor. Does thermoplasty have any application for bronchiectasis patients, like myself?”
Within the science AMA subsection, users have the ability to post a topic or questions about anything and respond to other users. AMA, which stands for “Ask Me Anything,” describes the conversation happening between the user and the host of the topic. Users have the ability to ask questions related to the topic, or even ‘upvote’ particular questions that they would like answered. An ‘upvote’ moves a question or comment to the top of the page to become more visible to the host. AMAs can become trending topics on Reddit through ‘upvotes’, as well.
In an effort to help educate and inform individuals on advancements in chest medicine education, clinical research, and team-based care, CHEST has connected specialists with a deep passion for topics in pulmonary, critical care, and sleep medicine to an audience filled with questions ready to be answered. Some of the topics we’ve covered include:
- Sepsis with Dr. Steven Q. Simpson, FCCP, who is a pulmonologist, intensivist, CHEST board member, and a sepsis researcher and expert. Dr. Simpson discussed the recent consensus statement on sepsis diagnosis. The statement aimed to redefine the diagnostic criteria of sepsis and eliminate the concept of the systemic inflammatory response syndrome (SIRS). Dr. Simpson shared his rebuttal New Sepsis Guidelines: A Change We Should Not Make in the journal CHEST. Dr. Simpson’s statement expressed the concern that widespread application of this new SIRS definition could cost patient lives, and it should not be adopted. This AMA was upvoted 784 times.
- Asthma and bronchial thermoplasty with Dr. D. Kyle Hogarth, FCCP, who is a pulmonologist, member of CHEST, and the first physician in Illinois to perform bronchial thermoplasty, a nonpharmaceutical treatment for severe asthma. This AMA was upvoted 3,112 times.
- DVT with Dr. Lisa K. Moores, FCCP, who is a pulmonologist, member of CHEST, and an expert on thrombosis. Dr. Moores discussed VTE, DVT, and PE. This AMA was upvoted 903 times.
Hosting Reddit AMAs has allowed CHEST to not only reach a more public-facing audience but also health-care providers outside of chest medicine. Stepping into this platform has allowed us to position CHEST as a subject matter expert in topics like asthma, sepsis, and DVT/VTE. These AMAs have helped people to understand the role our members play within health-care by showcasing new and emerging treatments and raising public awareness of health conditions.
If you are interested in sharing your knowledge on a specific topic on Reddit, you can contact CHEST’s New Media Specialist Taylor Pecko-Reid, at [email protected].
Drs. Simpson, Hogarth, and Moores told Reddit to ask them anything—here’s what happened next.
“Is there an organ or system that sepsis generally targets?”
“If I’m going to be in the back of a cramped car cross country for 16 hours straight, should I take an aspirin beforehand to cut down risk of DVT?”
“Hello Doctor. Does thermoplasty have any application for bronchiectasis patients, like myself?”
Within the science AMA subsection, users have the ability to post a topic or questions about anything and respond to other users. AMA, which stands for “Ask Me Anything,” describes the conversation happening between the user and the host of the topic. Users have the ability to ask questions related to the topic, or even ‘upvote’ particular questions that they would like answered. An ‘upvote’ moves a question or comment to the top of the page to become more visible to the host. AMAs can become trending topics on Reddit through ‘upvotes’, as well.
In an effort to help educate and inform individuals on advancements in chest medicine education, clinical research, and team-based care, CHEST has connected specialists with a deep passion for topics in pulmonary, critical care, and sleep medicine to an audience filled with questions ready to be answered. Some of the topics we’ve covered include:
- Sepsis with Dr. Steven Q. Simpson, FCCP, who is a pulmonologist, intensivist, CHEST board member, and a sepsis researcher and expert. Dr. Simpson discussed the recent consensus statement on sepsis diagnosis. The statement aimed to redefine the diagnostic criteria of sepsis and eliminate the concept of the systemic inflammatory response syndrome (SIRS). Dr. Simpson shared his rebuttal New Sepsis Guidelines: A Change We Should Not Make in the journal CHEST. Dr. Simpson’s statement expressed the concern that widespread application of this new SIRS definition could cost patient lives, and it should not be adopted. This AMA was upvoted 784 times.
- Asthma and bronchial thermoplasty with Dr. D. Kyle Hogarth, FCCP, who is a pulmonologist, member of CHEST, and the first physician in Illinois to perform bronchial thermoplasty, a nonpharmaceutical treatment for severe asthma. This AMA was upvoted 3,112 times.
- DVT with Dr. Lisa K. Moores, FCCP, who is a pulmonologist, member of CHEST, and an expert on thrombosis. Dr. Moores discussed VTE, DVT, and PE. This AMA was upvoted 903 times.
Hosting Reddit AMAs has allowed CHEST to not only reach a more public-facing audience but also health-care providers outside of chest medicine. Stepping into this platform has allowed us to position CHEST as a subject matter expert in topics like asthma, sepsis, and DVT/VTE. These AMAs have helped people to understand the role our members play within health-care by showcasing new and emerging treatments and raising public awareness of health conditions.
If you are interested in sharing your knowledge on a specific topic on Reddit, you can contact CHEST’s New Media Specialist Taylor Pecko-Reid, at [email protected].
Drs. Simpson, Hogarth, and Moores told Reddit to ask them anything—here’s what happened next.
“Is there an organ or system that sepsis generally targets?”
“If I’m going to be in the back of a cramped car cross country for 16 hours straight, should I take an aspirin beforehand to cut down risk of DVT?”
“Hello Doctor. Does thermoplasty have any application for bronchiectasis patients, like myself?”
Within the science AMA subsection, users have the ability to post a topic or questions about anything and respond to other users. AMA, which stands for “Ask Me Anything,” describes the conversation happening between the user and the host of the topic. Users have the ability to ask questions related to the topic, or even ‘upvote’ particular questions that they would like answered. An ‘upvote’ moves a question or comment to the top of the page to become more visible to the host. AMAs can become trending topics on Reddit through ‘upvotes’, as well.
In an effort to help educate and inform individuals on advancements in chest medicine education, clinical research, and team-based care, CHEST has connected specialists with a deep passion for topics in pulmonary, critical care, and sleep medicine to an audience filled with questions ready to be answered. Some of the topics we’ve covered include:
- Sepsis with Dr. Steven Q. Simpson, FCCP, who is a pulmonologist, intensivist, CHEST board member, and a sepsis researcher and expert. Dr. Simpson discussed the recent consensus statement on sepsis diagnosis. The statement aimed to redefine the diagnostic criteria of sepsis and eliminate the concept of the systemic inflammatory response syndrome (SIRS). Dr. Simpson shared his rebuttal New Sepsis Guidelines: A Change We Should Not Make in the journal CHEST. Dr. Simpson’s statement expressed the concern that widespread application of this new SIRS definition could cost patient lives, and it should not be adopted. This AMA was upvoted 784 times.
- Asthma and bronchial thermoplasty with Dr. D. Kyle Hogarth, FCCP, who is a pulmonologist, member of CHEST, and the first physician in Illinois to perform bronchial thermoplasty, a nonpharmaceutical treatment for severe asthma. This AMA was upvoted 3,112 times.
- DVT with Dr. Lisa K. Moores, FCCP, who is a pulmonologist, member of CHEST, and an expert on thrombosis. Dr. Moores discussed VTE, DVT, and PE. This AMA was upvoted 903 times.
Hosting Reddit AMAs has allowed CHEST to not only reach a more public-facing audience but also health-care providers outside of chest medicine. Stepping into this platform has allowed us to position CHEST as a subject matter expert in topics like asthma, sepsis, and DVT/VTE. These AMAs have helped people to understand the role our members play within health-care by showcasing new and emerging treatments and raising public awareness of health conditions.
If you are interested in sharing your knowledge on a specific topic on Reddit, you can contact CHEST’s New Media Specialist Taylor Pecko-Reid, at [email protected].